Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Drugs Limited submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India), the company's Registrar and Transfer Agent. The filing confirms that all securities received from depository participants for dematerialization during the quarter were duly confirmed (accepted or rejected) and reported to depositories. It also confirms that security certificates were mutilated and cancelled after verification, and depository names were substituted in the register of members within the prescribed timelines. This is a standard quarterly regulatory compliance filing.
This is a routine regulatory compliance filing with no direct impact on the company's financials or stock price. It confirms that the dematerialization process for the quarter was handled properly and within SEBI timelines.